Sign in

CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company

CURIS INC

Sign in to watch
Ticker
CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043505116
Phone
617-503-6500
Business address
128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
  1. 8-K/A Event Bylaws or fiscal year change
  2. 8-K Event Bylaws or fiscal year change
  3. 8-K Event Shareholder vote results
  4. DEF 14A Proxy Proxy Statement
  5. PRE 14A Proxy Proxy Statement (Preliminary)
  6. 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 8-K Event Delisting notice
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. ARS Other Annual Report to Security Holders
  14. DEF 14A Proxy Proxy Statement
  15. PRE 14A Proxy Proxy Statement (Preliminary)
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 4 Open-market buy Director bought 10,000 shares at $0.55 ($5,487)
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. 10-K Report Annual Report

Page 2 of 61 · 1,213 filings